Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results

BACKGROUND: Taxanes are major drugs for metastatic breast cancer (MBC) treatment, and are generally well tolerated, making them attractive for therapeutic reintroduction (rechallenge) during metastatic course. In view of the paucity of current literature, we questioned the usefulness of taxane recha...

Descripción completa

Detalles Bibliográficos
Autores principales: Réda, Manon, Fouquier, Anaïs, Desmoulins, Isabelle, Mayeur, Didier, Kaderbhai, Courèche, Ilie, Silvia, Hennequin, Audrey, Coudert, Bruno, Bertaut, Aurélie, Ladoire, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941511/
https://www.ncbi.nlm.nih.gov/pubmed/36773403
http://dx.doi.org/10.1016/j.breast.2023.01.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941511/
https://www.ncbi.nlm.nih.gov/pubmed/36773403
http://dx.doi.org/10.1016/j.breast.2023.01.015

Ejemplares similares